TRPV4 Gene Mutation

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Actio Biosciences
Actio BiosciencesCA - San Diego
1 program
The Natural History of TRPV4 NeuropathyN/A1 trial
Active Trials
NCT05600764RecruitingEst. Dec 2048

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
2027
2028
2029
2030
2031
Actio BiosciencesThe Natural History of TRPV4 Neuropathy

Clinical Trials (1)

NCT05600764Actio BiosciencesThe Natural History of TRPV4 Neuropathy

The Natural History of TRPV4 Neuropathy

Start: Dec 2023Est. completion: Dec 2048
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
1 companies competing in this space